Clinical trial

Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents

NCT00249886

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Citalopram Normalized identity: citalopramView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2002-09-01

PhasePHASE3

Conditions

Major Depressionverified · MONDO: major depressive disorder

Interventions

CitalopramDRUG · verified · RxNorm: citalopram

Sponsors & collaborators

Sunnybrook Health Sciences Centrelead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00249886 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.